Popular Cancer Pill Goes Generic, Yet Patients’ Costs Stay High

Donald Jones used to pay at least $500 a month for a brand-name drug, Gleevec, that’s kept his leukemia at bay for five years. Lately, he’s been paying almost as much for a generic ...

Cancer patients skipping medicines or delaying treatment due to high drug prices

John Krahne received alarming news from his doctor last December. His brain tumors were stable, but his lung tumors had grown noticeably larger. The doctor recommended a drug called ...

How Big Pharma Exploits the Cancer Drug Market

With another day, another headline arrives revealing the arrogant, out-of-touch nature of the pharmaceutical industry. Fortunately, this time, the outrage arrives from overseas. Specifically, ...

When Money Motivates Cancer Treatment Options

Last week, Dr. Pearl kicked off a three-part series on economic biases in medicine. His first installment revealed how money motivates bias in medical research. Today’s article follows ...

Cancer Survivor Shows Obamacare Unleashing Startups: Economy

Maksim Tsvetovat and Tatyana Kanzaveli say they doubt they could have started their data-collection company, Open Cancer Network, without Obamacare. Tsvetovat, 37 and the father of ...

Generic cancer drug – access not guaranteed

The government of India won a landmark case earlier this year against the drug’s inventor, Novartis, by rejecting the company’s patent on a crystallised form of the drug, ...

How Obamacare Will Harm Cancer Patients

Obamacare is going to degrade medicine but its ill effects will fall disproportionately on patients with serious conditions, especially those diagnosed with cancer. The legislation ...
© 2017 US Health Care Costs. All rights reserved. Site Admin · Entries RSS · Comments RSS
Powered by WordPress · Designed by Theme Junkie